FERRARESE, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.424
AS - Asia 5.611
EU - Europa 2.694
AF - Africa 961
SA - Sud America 869
Continente sconosciuto - Info sul continente non disponibili 208
OC - Oceania 80
Totale 19.847
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.789
SG - Singapore 1.785
CN - Cina 918
VN - Vietnam 807
IT - Italia 798
HK - Hong Kong 560
BR - Brasile 529
BD - Bangladesh 338
DE - Germania 206
FR - Francia 170
IN - India 170
FI - Finlandia 165
PL - Polonia 143
SE - Svezia 137
NL - Olanda 126
CA - Canada 117
GB - Regno Unito 112
RU - Federazione Russa 84
TR - Turchia 83
JP - Giappone 75
AR - Argentina 73
IQ - Iraq 64
ES - Italia 61
MX - Messico 60
PH - Filippine 56
KR - Corea 54
AT - Austria 50
PK - Pakistan 46
ZA - Sudafrica 44
SA - Arabia Saudita 43
UA - Ucraina 43
EC - Ecuador 42
JM - Giamaica 42
PY - Paraguay 42
CR - Costa Rica 41
UZ - Uzbekistan 41
ID - Indonesia 40
BE - Belgio 39
EG - Egitto 38
JO - Giordania 38
VE - Venezuela 38
NP - Nepal 37
RO - Romania 36
CO - Colombia 35
CI - Costa d'Avorio 33
MA - Marocco 33
SN - Senegal 33
BF - Burkina Faso 32
CZ - Repubblica Ceca 32
DZ - Algeria 31
HN - Honduras 31
CL - Cile 30
NI - Nicaragua 30
TN - Tunisia 30
AZ - Azerbaigian 29
EE - Estonia 29
IE - Irlanda 29
PR - Porto Rico 29
TW - Taiwan 29
ZM - Zambia 29
AM - Armenia 28
GH - Ghana 28
KG - Kirghizistan 28
LV - Lettonia 28
BY - Bielorussia 27
CV - Capo Verde 27
LC - Santa Lucia 27
MW - Malawi 26
NO - Norvegia 26
RE - Reunion 26
UG - Uganda 26
AL - Albania 25
AO - Angola 25
BJ - Benin 25
GT - Guatemala 25
BB - Barbados 24
IL - Israele 24
MY - Malesia 24
CM - Camerun 23
DO - Repubblica Dominicana 23
GR - Grecia 23
SO - Somalia 23
YE - Yemen 23
CY - Cipro 22
ET - Etiopia 22
GP - Guadalupe 22
KE - Kenya 22
LY - Libia 22
MK - Macedonia 22
PE - Perù 22
SK - Slovacchia (Repubblica Slovacca) 22
TT - Trinidad e Tobago 22
BG - Bulgaria 21
BS - Bahamas 21
GA - Gabon 21
GE - Georgia 21
HR - Croazia 21
IR - Iran 21
KZ - Kazakistan 21
LB - Libano 21
Totale 18.654
Salva come PNG Salva come JPEG
Città #
Ashburn 1.117
Singapore 1.117
San Jose 1.019
Fairfield 833
New York 650
Hong Kong 487
Woodbridge 395
Houston 378
Chandler 290
Seattle 274
Ann Arbor 272
Cambridge 265
Ho Chi Minh City 259
Los Angeles 226
Santa Clara 225
Wilmington 208
Hanoi 185
Beijing 163
Boardman 133
San Diego 110
Milan 107
Lauterbourg 94
Bytom 92
Helsinki 92
Council Bluffs 90
Dallas 88
Medford 73
Princeton 73
Rome 69
Des Moines 60
Padova 59
Chicago 53
Roxbury 53
São Paulo 51
Munich 50
Guangzhou 47
Da Nang 46
Buffalo 45
Denver 45
Phoenix 43
Orem 42
The Dalles 42
Tokyo 40
San Francisco 37
Haiphong 36
Hefei 35
Amman 34
Tashkent 34
Frankfurt am Main 33
Toronto 33
Dakar 32
Nuremberg 32
London 31
Nanjing 31
Abidjan 30
Managua 30
Montreal 30
Warsaw 30
Brooklyn 29
Lusaka 29
San José 29
Vienna 28
Baku 27
Kingston 27
Naples 27
Castries 26
Atlanta 25
Bishkek 25
Cotonou 25
Johannesburg 25
Kampala 25
Ouagadougou 25
Stockholm 25
Boston 24
Bridgetown 23
Riga 23
Yerevan 23
Accra 22
Amsterdam 22
Baghdad 22
Chennai 22
Kigali 21
Luanda 21
Nassau 21
Praia 21
Redondo Beach 21
Andorra la Vella 20
Charlotte 20
Libreville 20
Tallinn 20
Villafranca Padovana 20
Bamako 19
Dublin 19
Dushanbe 19
Istanbul 19
Rio de Janeiro 19
Seoul 19
Shanghai 19
Ulan Bator 19
Lappeenranta 18
Totale 11.501
Salva come PNG Salva come JPEG
Nome #
Liver transplantation for viral hepatitis in 2015 615
Bacterial Infections in End-Stage Liver Disease: Implications for Liver Transplantation 559
Therapeutic approaches for portal biliopathy: A systematic review 424
Frailty and sarcopenia in patients with cirrhosis awaiting liver transplantation: evidence from a single-centre, prospective cohort study 410
Markers of acute rejection and graft acceptance in liver transplantation. 286
Evolution of Liver Transplantation Indications: Expanding Horizons 285
In-Hospital Screening Campaign Against Hepatitis C Could Be Effective for Identifying More Patients Who Still Need Treatment 283
Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation - a multicenter cohort study 282
Liver transplantation for HBV-related liver disease: Impact of prophylaxis for HBV on HCC recurrence 279
Short-term outcomes of pediatric liver transplant recipients after transition to Adult Healthcare Service 277
Drop-out rate from the liver transplant waiting list due to HCC progression in HCV-infected patients treated with direct acting antivirals. 259
Alcoholic Etiology, Severity of Liver Disease, and Post-Transplant Adherence Are Correlated with Worse Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) in Liver Transplant Candidates 258
Obliterative portal venopathy without portal hypertension: An underestimated condition 258
An untreatable dyspnoea: more defendants under investigation 257
New Perspectives on Treatment of Hepatitis B Before and After Liver Transplantation 256
Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma 246
HCV eradication is not associated with drop-out due to HCC progression in patients awaiting liver transplantation: A monocentric experience 241
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and Delta cohort 239
Trends in liver transplantation for primary sclerosing cholangitis 237
Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites 236
PREVALENCE AND RISK FACTORS OF METABOLIC SYNDROME AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE 231
Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy 230
Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis 227
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study 225
Geotrichum capitatum Invasive Infection Early After Liver Transplant 223
Neuropsychiatric performance and treatment of hepatitis C with direct-acting antivirals: a prospective study 222
Prevalence and risk factors of metabolic syndrome after liver transplantation: a single centre experience 221
Antibiotic prophylaxis for preventing postorthotopic liver transplant tuberculosis: is there a safe alternative to isoniazid? 217
A prospective longitudinal assessment of de novo metabolic syndrome after liver transplantation 217
Current and future perspective on targeted agents and immunotherapies in hepatocellular carcinoma 213
Management of bacterial infection in the liver transplant candidate 212
PERIPHERAL NK CELLS IN PATIENTS WITH HCV RECURRENCE AFTER LIVER TRANSPLANTATION DURING INTERFERON-FREE ANTIVIRAL THERAPY 211
Hepatocellular carcinoma risk in patients with HBV-related liver disease receiving antiviral therapy 209
Acute alcoholic hepatitis and liver transplantation: Waiting for Godot 207
Health-related Quality of Life in Liver Transplantation: Another Step Forward 207
Allocation of liver grafts worldwide – Is there a best system? 205
Development of a Risk Prediction Model for Carbapenem-Resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study 204
EFFECTS OF NON-SELECTIVE beta-BLOCKERS ON HEMODYNAMICS AFTER LARGE VOLUME PARACENTESIS IN PATIENTS WITH CIRRHOSIS LISTED FOR LIVER TRANSPLANTATION: A PRELIMINARY REPORT 203
Eradication of HCV in patients awaiting liver transplantation does not increase drop-out due to HCC progression 203
Hepatitis C virus infection in end stage renal disease and kidney transplantation 201
Outcome of critically ill cirrhotic patients admitted to the ICU: The role of ACLF 199
Biodegradable Biliary Stents for Percutaneous Treatment of Post-liver Transplantation Refractory Benign Biliary Anastomotic Strictures 199
Chronic Hepatitis B in the Transplant Setting: A 30-Year Experience in a Single Tertiary Italian Center 196
Effect of Portal Vein Thrombosis (pvt) On Survival After Liver Transplantation (lt): A Metanalysis 194
Outcomes of liver transplant for adults with Wilson's disease 194
Antibiotic therapy for spontaneous bacterial peritonitis in acute-on-chronic liver failure: Handle with care 194
Current challenges and future directions for liver transplantation 189
Outcome of a First Episode of Bacterial Infection in Candidates for Liver Transplantation 189
Safe pregnancy after liver transplantation: Evidence from a multicenter Italian collaborative study 189
Drop-out rate due to HCC progression is not affected by HCV eradication with DAAs in patients awaiting liver transplantation 188
Hypercoagulability in cirrhotic patients with hepatocellular carcinoma (HCC) and portal vein thrombosis (PVT) 185
Effects of Non-Selective beta-Blockers on Hemodynamics and Paracentesis Induced Circulatory Dysfunction in Patients with Cirrhosis Undergoing Large Volume Paracentesis: a Preliminary Report 181
Orthotopic Liver Transplantation in Alcoholic Liver Disease Patients 180
Recent advances in understanding and managing liver transplantation 179
Letter: clinical outcomes of patients with hepatitis D infection in the liver transplant setting 176
Quality of life and adherence in liver transplant recipients 172
The role of an integrated referral program for patients with liver disease: A network between hub and spoke centers 171
Beneficial role of terlipressin in decompensated cirrhotics with spontaneous bacterial peritonitis 169
Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection 169
Hypercoagulability In Cirrhotic Patients With Hepatocellular Carcinoma (hcc) and Portal Vein Thrombosis (pvt) 165
Successful pregnancy in Alagille Syndrome. 160
Long-Term Impact of Direct-Acting Antivirals on Liver Fibrosis and Survival in HCV-Infected Liver Transplant Recipients 159
At the earliest: a Hub and Spoke referral and referral-back pilot project increases access to liver transplantation and ensures good long-term care 159
Sexual health and function in liver disease 159
An Essential Guide for Managing Post-Liver Transplant Patients: What Primary Care Physicians Should Know 156
Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysis 155
A Commentary on the Interplay Between Severity of Liver Disease and Bacterial Infection in Hospitalized Patients with Cirrhosis 155
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 145
Progetto pilota di strutturazione e implementazione di interventi di cura ed educazione sanitaria ad hoc per giovani ragazzi trapiantati di fegato 142
Risk Factors for Central Pontine and Extrapontine Myelinolysis After Liver Transplantation: A Single Center Study. 139
Hepatitis B and liver transplantation 133
A Combined Baveno VII and Spleen Stiffness Algorithm to Improve the Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease 132
Liver transplantation for Wilson disease: Current knowledge and future perspectives 132
Rethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertension 132
SPONTANEOUS BACTERIAL PERITONITIS (SBP) IS NOT ASSOCIATED WITH HIGHER MORTALITY IF COMPARED WITH OTHER INFECTIONS IN PATIENTS AWAITING LIVER TRANSPLANTATION (LT) 132
Predicting survival in patients with 'non-high-risk' acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding 131
Invasive fungal infection before and after liver transplantation 131
Prognostic models in end stage liver disease 129
Editorial: Assessing the Prognosis of Patients With HBV and ACLF—Comorbidities Matter 129
Transjugular intrahepatic portosystemic shunt in non-cirrhotic portal hypertension related to cystic fibrosis in a lung transplant patient 127
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 126
Validation of the INCREMENT‐SOT‐CPE score in a large cohort of liver transplant recipients with carbapenem‐resistant Enterobacterales infection 126
Physical Condition, Glycemia, Liver Function, and Quality of Life in Liver Transplant Recipients After a 12-Month Supervised Exercise Program 123
CIRCULATING MICROPARTICLES AND RISK OF PORTAL VEIN THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA 122
Pre-liver Transplant Functional Status: Refining Assessment and Outcomes for MASLD Patients 120
Machine learning in liver transplantation: a tool for some unsolved questions? 119
Whole blood coagulation tests are not equally able to detect haemostatic prothrombotic alterations in patients with liver cirrhosis and hepatocellular carcinoma (HCC): rotational thromboelastometry versus thrombingeneration test 117
The Need for Consensus About Liver Transplantation For Patients With Neuropsychiatric Wilson’s Disease 115
Evolution of liver fibrosis in diabetic patients with NAFLD in a follow-up study: Hepatoprotective effects of sodium-glucose co-transporter-2 inhibitors 111
Letter: Addressing Gaps in Hospital-Based Hepatitis C Screening-Insights and Recommendations. Authors' Reply' 108
We need evidence-based futility thresholds to transplant grade-3 acute on chronic liver failure patients with poor respiratory, haemodynamic, and metabolic parameters 107
CIRCULATING MICROPARTICLES AND RISK OF PORTAL VEIN THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA 106
Presepsin as a biomarker of inflammation and prognosis in decompensated liver disease 105
Spontaneous bleeding or thrombosis in cirrhosis: What should be feared the most? 102
The non-invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study 102
Toward a more precise prognostic stratification in acute decompensation of cirrhosis: The Padua model 2.0 96
WHOLE BLOOD COAGULATION TESTS ARE NOT EQUALLY ABLE TO DETECT HAEMOSTATIC PROTHROMBOTIC ALTERATIONS IN PATIENTS WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA: ROTATIONAL THROMBOELASTOMETRY VERSUS THROMBINGENERATION TEST 95
Donor/Recipient Gender Mismatch Modifies the Impact of Donor Age on Graft Survival Following Liver Transplantation 94
Transplanting severely obese cirrhotic patients: Heavy clouds still on the horizon 91
HBV-positive and HIV-positive organs in transplantation: a clinical guide for the hepatologist 91
Totale 19.166
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.495
article - articoli 51.759
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 423
Totale 106.677
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.074 0 127 112 72 33 116 94 105 37 47 108 223
2022/2023640 132 57 28 52 129 59 8 45 84 3 34 9
2023/2024553 25 84 53 46 43 49 64 23 21 36 60 49
2024/20252.378 6 185 105 92 238 77 128 162 212 90 400 683
2025/202611.689 529 719 1.512 1.616 817 930 1.535 825 1.094 590 1.008 514
2026/2027795 666 129 0 0 0 0 0 0 0 0 0 0
Totale 19.847